XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.2
Balance Sheet Components (Tables)
6 Months Ended
Jun. 30, 2023
Balance Sheet Related Disclosures [Abstract]  
Schedule of Inventory

Inventory consisted of the following:

 

 

 

June 30,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Raw materials

 

$

8,858

 

 

$

5,757

 

Work-in-progress

 

 

23,871

 

 

 

25,052

 

Finished goods

 

 

14,117

 

 

 

25,088

 

Total inventory

 

$

46,846

 

 

$

55,897

 

Schedule Of Other Accrued Liabilities

Other accrued liabilities consisted of the following:

 

 

 

June 30,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Accrued contract manufacturing expenses

 

$

6,077

 

 

$

8,382

 

Accrued clinical expenses

 

 

514

 

 

 

692

 

Accrued research expenses

 

 

307

 

 

 

349

 

Accrued professional services

 

 

7,299

 

 

 

3,977

 

Current portion of lease liabilities

 

 

1,226

 

 

 

1,316

 

Current portion of deferred royalty obligations

 

 

4,402

 

 

 

2,639

 

Accrued license fees and royalties

 

 

956

 

 

 

943

 

Other

 

 

1,721

 

 

 

2,909

 

Total other accrued liabilities

 

$

22,502

 

 

$

21,207

 

Schedule of Other Long-term Liabilities

Other long-term liabilities consisted of the following:

 

 

 

June 30,

 

 

December 31,

 

(in thousands)

 

2023

 

 

2022

 

Long-term portion of deferred royalty obligation

 

$

65,977

 

 

$

67,947

 

Long-term portion of lease liabilities

 

 

1,858

 

 

$

2,376

 

Contingent value rights liability

 

 

595

 

 

 

595

 

Other

 

 

154

 

 

 

 

Total other long-term liabilities

 

$

68,584

 

 

$

70,918